Medical News

RSS

Heart IT releases WebPAX cardiac echo reporting module

Heart IT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, announced today the release of the WebPAX cardiac echo reporting module.

10 Sep 2013

Paragon Bioservices awarded 2013 CMO Leadership Award for Quality and Reliability

Paragon Bioservices, a contract manufacturing organization whose expertise is the process development and manufacturing of biopharmaceuticals, announced today that it has been awarded the 2013 CMO Leadership Award for Quality and Reliability.

10 Sep 2013

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Omeros Corporation today announced that it recently submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market OMS302 for use in patients undergoing intraocular lens replacement surgery in the European Union.

10 Sep 2013

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim today announced the completion of patient enrolment for a Phase IIa clinical trial investigating a new interferon-free, all-oral, direct-acting antiviral combination treatment for patients with genotype-1a chronic hepatitis C virus infection.

10 Sep 2013

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.

10 Sep 2013

Life Technologies announces the Ion AmpliSeq Exome Certified Service Provider program

Life Technologies Corporation today announces the Ion AmpliSeq™ Exome Certified Service Provider program, a global organization of some of the world's top service providers that will sequence and analyze human exomes in as little as two days.

10 Sep 2013

Screening older people for minor memory changes may lead to harmful treatment

A political drive, led by the UK and US, to screen older people for minor memory changes (often called mild cognitive impairment or pre-dementia) is leading to unnecessary investigation and potentially harmful treatment for what is arguably an inevitable consequence of ageing, warn University of Sydney experts in in a paper published in the British Medical Journal today.

10 Sep 2013

First Edition: September 10, 2013

Today's headlines include reports from Capitol Hill about the GOP strategy to link debate of a stopgap spending bill to keep the government operating to efforts to defund the health law.

10 Sep 2013

New Atkins Candies help dieters satisfy their sweet tooth with low-carb option

Low-carb dieters now have an even sweeter way to melt off the pounds. Atkins Nutritionals, Inc., a leader in the weight-management category, announced today the launch of Atkins™ Candies, an indulgent line of bite-sized snacks that will be available nationwide beginning October 2013.

10 Sep 2013

Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

Power Balance Technologies Inc., sellers of the original Power Balance silicone wristband, today announces their year-long partnership with the National Breast Cancer Foundation, Inc. (NBCF) with the new 'Breast Cancer Awareness' Wristband.

10 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

SYNthesis med chem opens new medicinal chemistry unit in Cambridge's Babraham Research Campus

SYNthesis med chem, the global contract research organisation providing synthetic and medicinal chemistry services, today announced that the company has opened a new facility at the Babraham Research Campus in Cambridge, UK.

10 Sep 2013

New study reveals evaluation results of national anti-smoking campaign in USA

A comprehensive evaluation of the first ever federally-funded national smoking cessation campaign in the USA has revealed that the campaign may have helped at least 100 000 people in the USA to give up smoking, according to new results published in The Lancet.

10 Sep 2013

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of new approaches in pharmaco-imaging.

10 Sep 2013

Beverage coaster campaign reminds pregnant women on dangerous effects of alcohol

Before taking a sip of alcohol at nearly a dozen local bars and restaurants, San Diegans will be reminded of the dangers of mixing alcohol and pregnancy thanks to a beverage coaster campaign led by the new Southern California chapter of the National Organization on Fetal Alcohol Syndrome (SoCal NOFAS), in partnership with University of California, San Diego School of Medicine.

10 Sep 2013

New prescribing protocol could reduce potential misuse of antibiotics

Researchers have developed a new strategy for prescribing antibiotics that could reduce patient harm and help combat the rise in antibiotic resistance.

10 Sep 2013

Findings could lead to improvements in pneumonia care, outcomes for patients

An electronic decision support tool helped to reduce deaths from pneumonia in four hospital emergency departments in a new study.

10 Sep 2013

Metamark reports positive results from clinical validation study of prostate cancer prognostic test

Metamark Genetics, Inc., a privately-held biotechnology company, today announced positive results from a large clinical validation study of ProMark, its biopsy-based prostate cancer prognostic test.

10 Sep 2013

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche and Inovio Pharmaceuticals, Inc. announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.

10 Sep 2013

Medical News

Heart IT releases WebPAX cardiac echo reporting module

Paragon Bioservices awarded 2013 CMO Leadership Award for Quality and Reliability

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Life Technologies announces the Ion AmpliSeq Exome Certified Service Provider program

Screening older people for minor memory changes may lead to harmful treatment

First Edition: September 10, 2013

New Atkins Candies help dieters satisfy their sweet tooth with low-carb option

Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Patients with COPD show improvements in lung function with olodaterol

SYNthesis med chem opens new medicinal chemistry unit in Cambridge's Babraham Research Campus

New study reveals evaluation results of national anti-smoking campaign in USA

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Beverage coaster campaign reminds pregnant women on dangerous effects of alcohol

New prescribing protocol could reduce potential misuse of antibiotics

Findings could lead to improvements in pneumonia care, outcomes for patients

Metamark reports positive results from clinical validation study of prostate cancer prognostic test

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News